错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Rhythmic IL-17 production by γδ T cells maintains adipose de novo lipogenesis

  • Aaron Douglas,
  • Brenneth Stevens,
  • Miguel Rendas,
  • Harry Kane,
  • Evan Lynch,
  • Britta Kunkemoeller,
  • Karl Wessendorf-Rodriguez,
  • Emily A. Day,
  • Caroline Sutton,
  • Martin Brennan,
  • Katie O’Brien,
  • Ayano C. Kohlgruber,
  • Hannah Prendeville,
  • Amanda E. Garza,
  • Luke A. J. O’Neill,
  • Kingston H. G. Mills,
  • Christian M. Metallo,
  • Henrique Veiga-Fernandes,
  • Lydia Lynch

摘要

The circadian rhythm of the immune system helps to protect against pathogens13; however, the role of circadian rhythms in immune homeostasis is less well understood. Innate T cells are tissue-resident lymphocytes with key roles in tissue homeostasis47. Here we use single-cell RNA sequencing, a molecular-clock reporter and genetic manipulations to show that innate IL-17-producing T cells—including γδ T cells, invariant natural killer T cells and mucosal-associated invariant T cells—are enriched for molecular-clock genes compared with their IFNγ-producing counterparts. We reveal that IL-17-producing γδ (γδ17) T cells, in particular, rely on the molecular clock to maintain adipose tissue homeostasis, and exhibit a robust circadian rhythm for RORγt and IL-17A across adipose depots, which peaks at night. In mice, loss of the molecular clock in the CD45 compartment (Bmal1Vav1) affects the production of IL-17 by adipose γδ17 T cells, but not cytokine production by αβ or IFNγ-producing γδ (γδIFNγ) T cells. Circadian IL-17 is essential for de novo lipogenesis in adipose tissue, and mice with an adipocyte-specific deficiency in IL-17 receptor C (IL-17RC) have defects in de novo lipogenesis. Whole-body metabolic analysis in vivo shows that Il17a−/−Il17f−/− mice (which lack expression of IL-17A and IL-17F) have defects in their circadian rhythm for de novo lipogenesis, which results in disruptions to their whole-body metabolic rhythm and core-body-temperature rhythm. This study identifies a crucial role for IL-17 in whole-body metabolic homeostasis and shows that de novo lipogenesis is a major target of IL-17.